Governance Chugai Pharmaceutical Co., Ltd.

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 06:30:00 23/01/2026 GMT			5-day change	1st Jan Change
8,753.00 ^JPY	+4.20%		+1.85%	+6.19%

01-22	Protara Therapeutics, Inc. to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of Tara-002 in BCG-Unresponsive NMIBC Patients at the Asco Genitourinary Cancers Symposium	CI
12-30	Chugai Completes Merger With Renalys Pharma	MT

Executive Committee: Chugai Pharmaceutical Co., Ltd.

Manager

Positions heldSince

Osamu Okuda

62 year

Chief Executive Officer	31/12/2020
President	29/02/2020

Motoo Ueno

68 year

Comptroller/Controller/Auditor

29/02/2004

Iwaaki Taniguchi

Director of Finance/CFO	27/03/2024
Corporate Officer/Principal	31/12/2021

Junichi Nezu

Chief Tech/Sci/R&D Officer

Yoshiyuki Yano

Human Resources Officer

Shinji Hidaka

Sales & Marketing

Atsushi Sato

66 year

Comptroller/Controller/Auditor

28/02/2019

Yoko Kitagawa

Comptroller/Controller/Auditor	-
Investor Relations Contact	-

Junichi Ebihara

General Counsel

31/12/2014

Mamoru Togashi

69 year

Comptroller/Controller/Auditor

28/02/2017

Hisafumi Okabe

Chief Tech/Sci/R&D Officer

Composition of the Board of Directors: Chugai Pharmaceutical Co., Ltd.

Director

CommitteesSince

Christoph Franz

65 year

Compensation Committee Chair	01/04/2014
Nominating Committee Chair	31/12/2010
Governance Committee	01/04/2014
Nominating Committee	01/04/2014
Compensation Committee	31/12/2010

Masayuki Oku

81 year

Nominating Committee

31/07/2015

Motoo Ueno

68 year

Executive Committee

13/07/2011

Thomas Schinecker

51 year

Director/Board Member

Yoichiro Ichimaru

77 year

Director/Board Member	28/02/2017
Independent Dir/Board Member	28/02/2017

James H. Sabry

67 year

Director/Board Member

28/02/2019

Osamu Okuda

62 year

Director/Board Member

29/02/2020

Mariko Momoi

77 year

Director/Board Member	29/02/2020
Independent Dir/Board Member	29/02/2020

Iwaaki Taniguchi

Director/Board Member

27/03/2024

William Anderson

59 year

Director/Board Member

28/02/2019

Latest Appointments: Chugai Pharmaceutical Co., Ltd.

03/02/22	Chugai Pharmaceutical Co., Ltd. Announces Changes in Representative Directors and Directors, Effective March 29, 2022	CI
11/11/21	TIMELINE-Toshiba's lurch from crisis to crisis since 2015	RE
13/10/21	Synairgen : Appoints Chugai Pharma Executive as Chief Regulatory Officer	MT
28/06/21	Toshiba : board chairman lost re-election bid with 56% of votes opposed	RE
25/06/21	Toshiba : investor 3D Investment welcomes board changes	RE
22/06/21	Toshiba : board chair likely to scrape through with reappointment at crucial AGM - sources	RE
21/06/21	Toshiba : releases internal report ahead of shareholder vote	RE

More news

Former Officers and Directors: Chugai Pharmaceutical Co., Ltd.

Insider

Positions held

SinceUntil

Itagaki Toshiaki

Comptroller/Controller/Auditor	-	27/03/2024
Chief Tech/Sci/R&D Officer	-	27/03/2024
Director of Finance/CFO	-	27/03/2024

Osamu Nagayama

Director/Board Member	29/03/2020	25/06/2020
Chief Executive Officer	31/08/1992	31/12/2017
Chairman	29/02/2012	29/03/2020
Chief Operating Officer	14/01/2010	01/09/2010

Yoshio Itaya

Director/Board Member	29/07/2012	21/03/2018
Director of Finance/CFO	12/07/2011	21/03/2018
Corporate Officer/Principal	14/09/2010	19/09/2010

Masaaki Tohaya

Corporate Officer/Principal

30/03/2016

Toshihiko Tsuchiya

Corporate Officer/Principal	15/09/2010	30/03/2015
Corporate Secretary	08/02/2012	16/03/2015

Fumihiko Kamoshida

General Counsel

14/09/2010

30/03/2014

Naotaka Nakamura

Director/Board Member	14/01/2010	12/07/2011
Corporate Officer/Principal	14/01/2010	30/03/2014
Sales & Marketing	14/09/2010	12/07/2011

William Burns

Director/Board Member

30/09/2002

26/03/2014

Tatsumi Yamazaki

Director/Board Member	01/10/1980	26/03/2014
Corporate Officer/Principal	01/10/1980	08/05/2013

Franz Humer

Director/Board Member

30/09/2002

31/12/2013

Jean-Jacques Garaud

Corporate Officer/Principal

28/02/2010

26/03/2013

Yasuhiro Tsuji

Comptroller/Controller/Auditor

13/07/2011

26/03/2013

Daniel O'Day

Director/Board Member

28/02/2013

Sophie Kornowski-Bonnet

Director/Board Member

29/02/2012

Daniel Zabrowski

Director/Board Member

12/07/2011

Yasuo Ikeda

Director/Board Member	28/02/2010	-
Independent Dir/Board Member	28/02/2010	-

Pascal Soriot

Director/Board Member

15/09/2010

Erich Hunziker

Director/Board Member

14/01/2010

Kunitoshi Watanabe

Comptroller/Controller/Auditor	01/04/2013	-
Corporate Officer/Principal	15/09/2010	01/04/2013

Mitsuo Ohashi

Director/Board Member	14/01/2010	-
Independent Dir/Board Member	28/02/2005	-

Hiroaki Shigeta

Director/Board Member

31/05/2002

31/03/2003

Yutaka Tanaka

Director/Board Member	26/03/2014	-
Corporate Officer/Principal	14/01/2010	-
Sales & Marketing	12/07/2011	03/05/2012

Ryuzo Kodama

Director/Board Member	14/01/2010	-
Chief Tech/Sci/R&D Officer	12/07/2011	-
Director of Finance/CFO	14/01/2010	12/07/2011
Public Communications Contact	15/09/2010	12/07/2011
Corporate Officer/Principal	14/01/2010	18/01/2010

Martin B. Edelshain

Corporate Officer/Principal

31/12/1994

31/12/2001

Abraham E. Cohen

Director/Board Member

22/04/2012

Yohei Tanida

Corporate Officer/Principal

30/06/1998

Shunji Yokoyama

Comptroller/Controller/Auditor	28/02/2015	-
Corporate Officer/Principal	14/09/2010	08/05/2013

Kotaro Miwa

Comptroller/Controller/Auditor

12/07/2011

Tatsuro Kosaka

Director/Board Member	28/02/2010	31/03/2020
Chief Executive Officer	31/12/2017	-
Chairman	31/03/2020	-
Chief Operating Officer	29/07/2012	31/12/2017
Corporate Officer/Principal	31/05/2000	29/02/2012
President	29/02/2012	29/02/2020
Sales & Marketing	30/06/2005	29/02/2012

Shinichiro Iida

Corporate Officer/Principal

Hisanori Takanashi

Chief Tech/Sci/R&D Officer

Toshiya Sasai

Investor Relations Contact	-	-
Public Communications Contact	-	-

Haruki Yamazaki

Investor Relations Contact	-	-
Public Communications Contact	-	-

Mikio Sakai

Corporate Officer/Principal

Shinichi Nihira

Corporate Officer/Principal

Masahiko Uchida

Investor Relations Contact

Kazunori Yoshikawa

Corporate Officer/Principal

Minoru Hirose

Corporate Officer/Principal

Koki Harada

Public Communications Contact

Sadaaki Yokoyama

Chief Tech/Sci/R&D Officer

Abraham Sofaer

Corporate Officer/Principal

Hitoshi Kuboniwa

Corporate Officer/Principal

Michiharu Abe

General Counsel	18/01/2010	-
Corporate Officer/Principal	14/01/2010	14/09/2010

Jonathan Knowles

Director/Board Member

Yoshiki Yagi

Corporate Officer/Principal

Naoya Saishu

Corporate Officer/Principal

Harutaka Fujita

Director/Board Member	14/01/2010	-
Corporate Officer/Principal	14/01/2010	-

Christopher Murray

Director/Board Member	14/01/2010	-
Corporate Officer/Principal	14/01/2010	-

Severin Schwan

Director/Board Member

14/01/2010

Shigetoshi Matsumoto

Comptroller/Controller/Auditor

14/01/2010

Mikio Arisawa

Corporate Officer/Principal

14/01/2010

Hidetoshi Ushio

Chief Tech/Sci/R&D Officer	14/09/2010	12/07/2011
Corporate Officer/Principal	12/07/2011	-

Toshitaka Uto

Corporate Officer/Principal	12/07/2011	02/05/2013
Sales & Marketing	02/05/2013	-

Minoru Machida

Corporate Officer/Principal

14/09/2010

Tetsuo Minoura

Sales & Marketing

14/09/2010

Akio Tanaka

Corporate Officer/Principal	14/09/2010	12/07/2011
Sales & Marketing	12/07/2011	-

Katsuyori Kunii

Corporate Officer/Principal

15/09/2010

Keiji Shima

Corporate Officer/Principal

15/09/2010

Susumu Kato

Sales & Marketing

31/12/2014

Hideaki Nagai

Chief Tech/Sci/R&D Officer

15/09/2010

Mitsuru Kikuchi

Public Communications Contact	08/02/2012	-
Corporate Officer/Principal	15/09/2010	08/02/2012

Tomoyuki Nakayama

Corporate Officer/Principal

15/09/2010

Yoichi Yamanaka

Corporate Officer/Principal

15/09/2010

Juzo Ueno

Founder

01/03/1925

Age distribution of managers

Parity Men Women

Male	22
Female	2

Of which Executive Committee

Male	10
Female	1

Of which Directors

Male	9
Female	1

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Employees

5,026

Sector

Pharmaceuticals

Calendar

01-28 - Q4 2025 Earnings Release

More about the company